Accessibility Menu
 
Biotricity logo

Biotricity

(OTC) BTCY

Current Price$0.26
Market Cap$7.52M
Since IPO (2016)-98%
5 Year-89%
1 Year-45%
1 Month+9%

Biotricity Financials at a Glance

Market Cap

$7.52M

Revenue (TTM)

$15.45M

Net Income (TTM)

$4.02M

EPS (TTM)

$-0.18

P/E Ratio

-1.49

Dividend

$0.00

Beta (Volatility)

1.73 (High)

Price

$0.26

Volume

60,422

Open

$0.24

Previous Close

$0.26

Daily Range

$0.24 - $0.26

52-Week Range

$0.20 - $0.75

BTCY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biotricity

Industry

Health Care Technology

Employees

46

CEO

Waqaas Al-Siddiq, PhD, MBA

Headquarters

Redwood City, CA 94065, US

BTCY Financials

Key Financial Metrics (TTM)

Gross Margin

81%

Operating Margin

1%

Net Income Margin

-26%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-71%

Earnings Yield

-67.11%

Dividend Yield

0.00%

Payout Ratio

-0.60%

Stock Overview

Market Cap

$7.52M

Shares Outstanding

28.60M

Volume

60.42K

Avg. Volume

40.87K

Financials (TTM)

Gross Profit

$10.56M

Operating Income

$2.45M

EBITDA

$3.21M

Operating Cash Flow

$2.38M

Capital Expenditure

$3.00

Free Cash Flow

$2.38M

Cash & ST Invst.

$365.14K

Total Debt

$26.09M

Biotricity Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$3.99M

+10.2%

Gross Profit

$3.25M

+17.6%

Gross Margin

81.54%

N/A

Market Cap

$7.52M

N/A

Market Cap/Employee

$136.64K

N/A

Employees

55

N/A

Net Income

$717.07K

+41.7%

EBITDA

$440.92K

+606.8%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$26.83M

-7.6%

Accounts Receivable

$1.58M

-43.3%

Inventory

$1.97M

+25.8%

Long Term Debt

$13.00M

-1.0%

Short Term Debt

$14.09M

+14.3%

Return on Assets

-70.62%

N/A

Return on Invested Capital

-0.78%

N/A

Free Cash Flow

$740.29K

-740.4%

Operating Cash Flow

$740.29K

-740.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMMVFImmunovia AB (publ)
$0.02+0.00%
ALRTFALR Technologies Inc.
$0.01-23.33%
ASAPFAurora Spine Corporation
$0.19-4.97%
GTHPGuided Therapeutics, Inc.
$0.23-6.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$99.62+0.05%
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%

Questions About BTCY

What is the current price of Biotricity?

Biotricity is trading at $0.26 per share.

What is the 52-week range for Biotricity?

Over the past 52 weeks, Biotricity has traded between $0.20 and $0.75.

How much debt does Biotricity have?

As of the most recent reporting period, Biotricity reported total debt of $27.09M.

How much cash does Biotricity have on hand?

Biotricity reported $256,357 in cash and cash equivalents in its most recent financial results.

What is Biotricity’s dividend yield?

Biotricity does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.